Loading...
iAnthus Capital Holdings, Inc.
IAN.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.005
CA$0.00(0.00%)
iAnthus Capital Holdings, Inc. (IAN.CN) Financial Performance & Statements
Review iAnthus Capital Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
5.23%
↑ 5.23%
Operating Income Growth
79.09%
↑ 79.09%
Net Income Growth
90.03%
↑ 90.03%
Operating Cash Flow Growth
315.78%
↑ 315.78%
Operating Margin
-5.94%
↓ 5.94%
Gross Margin
41.04%
↑ 41.04%
Net Profit Margin
-4.52%
↓ 4.52%
ROE
9.62%
↑ 9.62%
ROIC
-5.08%
↓ 5.08%
iAnthus Capital Holdings, Inc. (IAN.CN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for iAnthus Capital Holdings, Inc. stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $167.57M | $159.24M | $163.21M | $203.02M |
| Cost of Revenue | $92.45M | $96.07M | $88.78M | $91.73M |
| Gross Profit | $75.11M | $63.17M | $74.43M | $111.28M |
| Gross Profit Ratio | $0.45 | $0.40 | $0.46 | $0.55 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $59.87M | $64.73M | $112.39M | $96.97M |
| Operating Expenses | $83.63M | $103.88M | $144.65M | $127.48M |
| Total Costs & Expenses | $176.08M | $199.95M | $233.43M | $219.22M |
| Interest Income | $5.16M | $1.85M | $86000.00 | $517000.00 |
| Interest Expense | $21.80M | $30.16M | $22.25M | $32.67M |
| Depreciation & Amortization | $24.74M | $27.17M | $31.39M | $31.04M |
| EBITDA | $20.20M | -$2.59M | -$25.02M | $7.96M |
| EBITDA Ratio | $0.12 | -$0.02 | -$0.15 | $0.08 |
| Operating Income | -$8.51M | -$40.71M | -$70.22M | -$14.11M |
| Operating Income Ratio | -$0.05 | -$0.26 | -$0.43 | -$0.07 |
| Other Income/Expenses (Net) | -$16.80M | -$19.21M | -$326.25M | -$31.97M |
| Income Before Tax | -$25.31M | -$59.92M | -$438.70M | -$54.00M |
| Income Before Tax Ratio | -$0.15 | -$0.38 | -$2.69 | -$0.27 |
| Income Tax Expense | -$17.68M | $16.70M | $10.69M | $22.25M |
| Net Income | -$7.64M | -$76.62M | -$449.39M | -$76.25M |
| Net Income Ratio | -$0.05 | -$0.48 | -$2.75 | -$0.38 |
| EPS | -$0.001 | -$0.01 | -$0.13 | -$0.44 |
| Diluted EPS | -$0.001 | -$0.01 | -$0.13 | -$0.44 |
| Weighted Avg Shares Outstanding | $6.54B | $6.44B | $3.37B | $171.72M |
| Weighted Avg Shares Outstanding (Diluted) | $6.54B | $6.44B | $3.37B | $171.72M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan